Adapt to market changes in 2025 by embracing flexibility in investing, exploring non-traditional strategies, and seeking ways to add alpha.

Merit Financial Group LLC cut its holdings in shares of iShares Core High Dividend ETF (NYSEARCA:HDV – Free Report) by 18.7% ...

HDV's top holdings in consumer staples, energy, and healthcare sectors are expected to deliver robust earnings growth, enhancing its price and dividend returns. Investors with modest risk ...

The FDA has granted breakthrough therapy designation to Bluejay Therapeutics’ brelovitug for the treatment of chronic hepatitis delta, for which no approved therapies currently exist in the U.S., the ...

A smart beta exchange traded fund, the iShares Core High Dividend ETF (HDV) debuted on 03/29/2011, and offers broad exposure to the Style Box - Large Cap Value category of the market.

Global Commercial Vehicle Outlook 2025, Global medium & heavy commercial vehicle sales were 3.3 million units in 2024 and are ...

Generating income from your investments is a nice thing. After all, you'll earn money without punching a clock and answering ...

Detailed price information for High Dividend Ishares Core ETF (HDV-A) from The Globe and Mail including charting and trades.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

The drug has been granted Breakthrough Therapy designation by the FDA for the treatment of chronic hepatitis delta (CHD).